🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David P. Dearnaley

Royal Marsden NHS Foundation Trust

ORCID: 0000-0002-3954-2806

Also affiliated with Institute of Cancer Research, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Marsden Hospital

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.6Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.034
Top 5%
4.7DataRank
Top 5%141 citations

E.S. Paulson, Brian J. Davis, Daniel E. Spratt, Todd M. Morgan, David P. Dearnaley +20 more

Papers

Driven by 10 papers — median percentile 86. Top paper: “NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer”.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.034
Top 5%
4.7DataRank
Top 5%141 citations

E.S. Paulson, Brian J. Davis, Daniel E. Spratt, Todd M. Morgan, David P. Dearnaley +20 more

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00522-2
N/A
3.0DataRank · unranked
96 citations

Elizabeth Page, Mark N. Brook, Sarah Thomas, Natalie Taylor, Jennifer Pope +95 more

Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad088
Top 24%
0.843DataRank
Top 24%19 citations

Miguel E. Aguado‐Barrera, L.M.H. Schack, Leila Dorling, Tim Rattay, Laura Fachal +79 more

Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5070
N/A
0DataRank · unranked
8 citations

Akash Roy, Siyuan S Guo, Larysa Rydzewska, Peter J. Godolphin, Maha Hussain +15 more

Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.01535
N/A
0DataRank · unranked
29 citations

Akash Roy, Larysa Rydzewska, Siyuan Guo, Peter J. Godolphin, Maha Hussain +15 more

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer

Nature Communications(2024)10.1038/s41467-024-52472-6
N/A
0DataRank · unranked
11 citations

Thomas Kryza, Nathalie Bock, Brian Wan-Chi Tse, Kamil A. Sokolowski, Janaththani Panchadsaram +95 more

The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials

The Lancet Oncology(2025)10.1016/s1470-2045(24)00720-4
N/A
0DataRank · unranked
28 citations

Parsa Jamshidian, Alison Tree, Emma Hall, David P. Dearnaley, Jeff M. Michalski +23 more

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium

The Lancet Oncology(2025)10.1016/s1470-2045(25)00034-8
N/A
0DataRank · unranked
20 citations

Yilun Sun, Alison Tree, Emma Hall, David P. Dearnaley, Charles Catton +29 more

Considering benefit and risk before routinely recommending SpaceOAR

The Lancet Oncology(2020)10.1016/s1470-2045(20)30639-2
N/A
0DataRank · unranked
44 citations

Alison Tree, David P. Dearnaley, Christopher Parker, Vinay Prasad, Mack Roach +2 more

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)

European Urology(2022)10.1016/j.eururo.2022.07.011
N/A
0DataRank · unranked
63 citations

Fang‐I Chu, Howard M. Sandler, Felix Y. Feng, Jason A. Efstathiou, Christopher U. Jones +37 more